Amino-terminal parathyroid hormone fragment analogs containing α,α-di-alkyl amino acids at positions 1 and 3

Journal of Bone and Mineral Research

Volumn 19, Issue 12, 2004, Pages 2078-2086

  Shimizu, Naoto ^a,b   Dean, Thomas ^a   Khatri, Ashok ^a   Gardella, Thomas J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; ALANINE; AMINO ACID; CARBOXYLIC ACID DERIVATIVE; GLUTAMINE; GLYCINE DERIVATIVE; PARATHYROID HORMONE; PEPTIDE; TRYPTOPHAN; AMINO TERMINAL PARATHYROID HORMONE; AMINO-TERMINAL PARATHYROID HORMONE; CYCLIC AMP; INOSITOL PHOSPHATE; PEPTIDE FRAGMENT; PHOSPHOLIPASE C;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONFORMATION; HORMONE ACTION; NONHUMAN; PHARMACOPHORE; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; ANIMAL; CELL LINE; CELL STRAIN COS1; CHEMICAL MODEL; CHEMISTRY; CIRCULAR DICHROISM; DOSE RESPONSE; IC 50; METABOLISM; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SWINE;

AMINO ACIDS; ANIMALS; CELL LINE; CIRCULAR DICHROISM; COS CELLS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; INHIBITORY CONCENTRATION 50; INOSITOL PHOSPHATES; MODELS, CHEMICAL; PARATHYROID HORMONE; PEPTIDE FRAGMENTS; PEPTIDES; PHOSPHOLIPASE C; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; SWINE;

EID: 12544259198     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.040914     Document Type: Article

References (44)

1. Tregear GW, Van Rietschoten J, Greene E, Keutmann HT, Niall HD, Reit B, Parsons JA, Potts JT Jr 1973 Bovine parathyroid hormone: Minimum chain length of synthetic peptide required for biological activity. Endocrinology 93:1349-1353.
2. Nussbaum SR, Rosenblatt M, Potts JT Jr 1980 Parathyroid hormone renal receptor interactions. Demonstration of two receptor-binding domains. J Biol Chem 255:10183-10187.
3. Bergwitz C, Gardella TJ, Flannery MR, Potts JT Jr, Kronenberg HM, Goldring SR, Jüppner H 1996 Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. Evidence for a common pattern of ligand-receptor interaction. J Biol Chem 271:26469-26472.
4. Gensure R, Gardella T, Juppner H 2001 Multiple sites of contact between the carboxyl-terminal binding domain of PTHrP-(1-36) analogs and the amino-terminal extracellular domain of the PTH/PTHrP receptor identified by photoaffinity cross-linking. J Biol Chem 276:28650-28658.
5. Mannstadt M, Luck M, Gardella T, Jüppner H 1998 Evidence for a ligand interaction site at the amino-terminus of the parathyroid hormone (PTH)/PTH-related protein receptor from cross-linking and mutational studies. J Biol Chem 273:16890-16896.
6. Adams A, Bisello A, Chorev M, Rosenblatt M, Suva L 1998 Arginine 186 in the extracellular N-terminal region of the human parathyroid hormone 1 receptor is essential for contact with position 13 of the hormone. Mol Endocrinol 12:1673-1683.
7. Bisello A, Adams AE, Mierke D, Pellegrini M, Rosenblatt M, Suva L, Chorev M 1998 Parathyroid hormone-receptor interactions identified directly by photocross-linking and molecular modeling studies. J Biol Chem 273:22498-22505.
8. Greenberg Z, Bisello A, Mierke D, Rosenblatt M, Chorev M 2000 Mapping the bimolecular interface of the parathyroid hormone (PTH)-PTH1 receptor complex: spatial proximity between Lys(27) (of the hormone principal binding domain) and leu(26I) (of the first extracellular loop) of the human PTH1 receptor. Biochemistry 39:8142-8152.
9. Rölz C, Pellegrini M, Mierke D 1999 Molecular characterization of the receptor-ligand complex for parathyroid hormone. Biochemistry 38:6397-6405.
10. Jin L, Briggs S, Chandrasekhar S, Chirgadze N, Clawson D, Schevitz R, Smiley D, Tashjian A, Zhang F 2000 Crystal structure of human parathyroid hormone 1-34 at 0.9 - A resolution. J Biol Chem 275:27238-27244.
11. Monticelli L, Mammi S, Mierke D 2002 Molecular characterization of a ligand-tethered parathyroid hormone receptor. Biophys Chem 95:165-172.
12. Hoare S, Gardella T, Usdin T 2001 Evaluating the signal transduction mechanism of the parathyroid hormone 1 receptor. Effect of receptor-G-protein interaction on the ligand binding mechanism and receptor conformation. J Biol Chem 276:7741-7753.
13. Gardella TJ, Jüppner H 2001 Molecular properties of the PTH/PTHrP receptor. Trends Endocrinol Metab 12:210-217.
14. Rölz C, Mierke D 2001 Characterization of the molecular motions of constitutively active G protein-coupled receptors for parathyroid hormone. Biophys Chem 89:119-128.
15. Luck M, Carter P, Gardella T 1999 The (1-14) fragment of parathyroid hormone (PTH) activates intact and amino-terminally truncated PTH-1 receptors. Mol Endocrinol 13:670-680.
16. Shimizu M, Carter P, Khatri A, Potts JJ, Gardella T 2001 Enhanced activity in parathyroid hormone-(1-14) and -(1-11): Novel peptides for probing ligand-receptor interactions. Endocrinology 142: 3068-3074.
17. Shimizu N, Guo J, Gardella T 2001 Parathyroid hormone (PTH)-(1-14) and -(1-11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor. J Biol Chem 276:49003-49012.
18. Shimizu M, Potts JJ, Gardella T 2000 Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor. J Biol Chem 275:21836-21843.
19. Kaul R, Balaram P 1999 Stereochemical control of peptide folding. Bioorg Med Chem 7:105-117.
20. Bardi R, Piazzesi AM, Toniolo C, Sukumar M, Balaram P 1986 Stereochemistry of peptides containing 1-aminocyclopentane-carboxylic acid (Acc5): Solution and solid-state conformations of Boc-Acc5-Acc5-NHMe. Biopolymers 25:1635-1644.
21. Valle G, Crisma M, Toniolo C 1988 Linear oligopeptides. 188. Crystalographic characterization of the conformation of the 1-aminocyclopentane- 1-carboxylic acid residue in simple derivatives. Can J Chem 66:2575-2581.
22. 3 type III β-turn. Biopolymers 18:1635-1646.
23. Vijayalakshmi S, Rao RB, Karle IL, Balaram P 2000 Comparison of helix-stabilizing effects of alpha,alpha-dialkyl glycines with linear and cycloalkyl side chains. Biopolymers 53:84-98.
24. Takasu H, Guo J, Bringhurst F 1999 Dual signaling and ligand selectivity of the human PTH/PTHrP receptor. J Bone Miner Res 14:11-20.
25. Gardella TJ, Jüppner H, Wilson AK, Keutmann HT, Abou-Samra AB, Segre GV, Bringhurst FR, Potts JT Jr, Nussbaum SR, Kronenberg HM 1994 Determinants of [Arg2]PTH-(1-34) binding and signaling in the transmembrane region of the parathyroid hormone receptor. Endocrinology 135:1186-1194.
26. Shimizu M, Shimizu N, Tsang J, Petroni B, Khatri A, Potts JJ, Gardella T 2002 Residue 19 of the parathyroid hormone (PTH) modulates ligand interaction with the juxtamembrane region of the PTH-1 receptor. Biochemistry 41:13224-13233.
27. Berridge M, Dawson R, Downes C, Heslop J, Irvine R 1983 Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem J 212:473-482.
28. Iida-Klein A, Guo J, Takemura M, Drake MT, Potts JT Jr, Abou-Samra A, Bringhurst FR, Segre GV 1997 Mutations in the second cytoplasmic loop of the rat parathyroid hormone (PTH)/PTH-related protein receptor result in selective loss of PTH-stimulated phospholipase C activity. J Biol Chem 272:6882-6889.
29. Shigeno C, Hiraki Y, Westerberg DP, Potts JT Jr, Segre GV 1988 Photoaffinity labeling of parathyroid hormone receptors in clonal rat osteosarcoma cells. J Biol Chem 263:3864-3871.
30. Tawfeek HA, Che J, Qian F, Abou-Samra AB 2001 Parathyroid hormone receptor internalization is independent of protein kinase A and phospholipase C activation. Am J Physiol Endocrinol Metab 281:E545-E557.
31. Tsomaia N, Pellegrini M, Hyde K, Gardella TJ, Mierke DF 2004 Toward parathyroid hormone minimization: conformational studies of cyclic PTH(1-14) analogues. Biochemistry 43:690-699.
32. Piserchio A, Shimizu N, Gardella T, Mierke D 2002 Residue 19 of the parathyroid hormone: structural consequences. Biochemistry 41:13217-13223.
33. Behar V, Bisello A, Bitan B, Rosenblatt M, Chorev M 2000 Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor. J Biol Chem 275:9-17.
34. Gensure R, Carter P, Petroni B, Juppner H, Gardella T 2001 Identification of determinants of inverse agonism in a constitutively active parathyroid hormone/parathyroid hormone-related peptide receptor by photoaffinity cross-linking and mutational analysis. J Biol Chem 276:42692-42699.
35. Gardella TJ, Axelrod D, Rubin D, Keutmann HT, Potts JT Jr, Kronenberg HM, Nussbaum SR 1991 Mutational analysis of the receptor-activating region of human parathyroid hormone. J Biol Chem 266:13141-13146.
36. Carter P, Juppner H, Gardella T 1999 Studies of the N-terminal region of a parathyroid hormone-related peptide (1-36) analog: Receptor subtype-selective agonists, antagonists, and photochemical cross-linking agents. Endocrinology 140:4972-4981.
37. Cohen AE, Strewler GJ, Bradley MS, Carlquist M, Nilsson M, Ericsson M, Ciardelli TL, Nissenson RA 1991 Analogues of parathyroid hormone modified at positions 3 and 6. Effects on receptor binding and activation of adenylyl cyclase in kidney and bone. J Biol Chem 266:1997-2004.
38. Takasu H, Gardella T, Luck M, Potts JT Jr, Bringhurst F 1999 Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via the type 1 PTH receptor: Implications for design of signal-specific PTH ligands. Biochemistry 38:13453-13460.
39. Shimizu N, Tsang J, Khatri A, Gardella T 2003 Development of PTH(1-14)-based antagonist analogs that bind to the juxtamemrane portion of the PTH-1 receptor. J Bone Miner Res 18:S1;S176.
40. Nutt RF, Caulfield MP, Levy JJ, Gibbons SW, Rosenblatt M, McKee RL 1990 Removal of partial agonism from parathyroid hormone (PTH)-related protein-(7-34)NH2 by substitution of PTH amino acids at positions 10 and 11. Endocrinology 127:491-493.
41. Shimizu N, Petroni B, Khatri A, Gardella T 2003 Functional evidence for an intramolecular side chain interaction between residues 6 and 10 of receptor-bound parathyroid hormone analogues. Biochemistry 42:2282-2290.
42. Neer R, Arnaud C, Zanchetta J, Prince R, Gaich G, Reginster J, Hodsman A, Eriksen E, Ish-Shalom S, Genant H, Wang O, Mitlak B 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441.
43. Morley P, Whitfield J, Willick G 2001 Parathyroid hormone: An anabolic treatment for osteoporosis. Curr Pharm Des 7:671-687.
44. Hruby V, Qiu W, Okayama T, Soloshonok V 2001 In: Iyengar R, Hildebrandt J (eds.) Methods in Enzymology: G Protein Pathways. Part A: Receptors, vol. 343. Academic Press, San Diego, CA, USA, pp. 91-123.